Hitoshi Maeshima

Shizuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

A preliminary cross-sectional study of bipolarity and primary pharmacotherapy in long-term stable patients with major depressive disorder.

A preliminary cross-sectional study of bipolarity and primary pharmacotherapy in long-term stable patients with major depressive disorder.

Journal: International journal of bipolar disorders

Published: February 23, 2026

Serum Amyloid β Oligomer May Predict Treatment Response in Middle-Aged and Late-Life Patients With Depression.

Serum Amyloid β Oligomer May Predict Treatment Response in Middle-Aged and Late-Life Patients With Depression.

Journal: Neuropsychopharmacology reports

Published: February 01, 2026

Relationship Between Clozapine Levels and Adverse Effects Evaluated by the GASS-C in Treatment-Resistant Schizophrenia.

Relationship Between Clozapine Levels and Adverse Effects Evaluated by the GASS-C in Treatment-Resistant Schizophrenia.

Journal: Human psychopharmacology

Published: January 12, 2026

Cognitive impairment of medicated patients with remitted depression and low anticholinergic activity.

Cognitive impairment of medicated patients with remitted depression and low anticholinergic activity.

Journal: Journal of affective disorders

Published: March 21, 2024

Serum levels of brain-derived neurotrophic factor in remission, but not the acute phase, may predict the development from depression to dementia.

Serum levels of brain-derived neurotrophic factor in remission, but not the acute phase, may predict the development from depression to dementia.

Journal: International journal of geriatric psychiatry

Published: January 26, 2023

Clinical course and serum amyloid β levels in elderly patients with major depressive disorder.

Clinical course and serum amyloid β levels in elderly patients with major depressive disorder.

Journal: Journal of affective disorders

Published: March 31, 2022

Apolipoprotein E4 increases the risk of depression recurrence.

Apolipoprotein E4 increases the risk of depression recurrence.

Journal: Journal of affective disorders

Published: February 12, 2021

Serum levels and mutual correlations of amyloid β in patients with depression.

Serum levels and mutual correlations of amyloid β in patients with depression.

Journal: Geriatrics & gerontology international

Published: July 11, 2019

Serum levels of TDP-43 in late-life patients with depressive episode.

Serum levels of TDP-43 in late-life patients with depressive episode.

Journal: Journal of affective disorders

Published: September 27, 2018

Increased Serum Levels of α-Synuclein in Patients With Major Depressive Disorder.

Increased Serum Levels of α-Synuclein in Patients With Major Depressive Disorder.

Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

Published: August 20, 2018

Glucocorticoid may influence amyloid β metabolism in patients with depression.

Glucocorticoid may influence amyloid β metabolism in patients with depression.

Journal: Psychiatry research

Published: June 17, 2017

Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia.

Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia.

Journal: Neuroscience letters

Published: January 21, 2015

Showing 1-12 of 25

Last Updated: 09/26/2026